Condition: Colorectal Cancer · Liver Metastases · Liver Metastasis Colon Cancer · Sponsor: Amsterdam UMC, location VUmc
The primary objective of this phase IIb/III, prospective, randomized clinical trial is to compare the efficacy of irreversible electroporation (IRE) with stereotactic body radiotherapy (SBRT) in patients with perivascular or peribiliary colorectal liver metastases (CRLM), that are not amenable for surgical resection or thermal ablation. Efficacy is assessed in terms of local control at 2 years.
This description comes directly from the study's public registry record.
Danielle J. Vos, M.D. · +3120-4444571 · interventieradiologie@vumc.nl
Always discuss trial participation with your own doctor first.
| Amsterdam UMC - location VUmc | Amsterdam, North Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06185556